Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Lobar lung transplantation: One size fits all

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Expanding options to manage traumatic thoracic vascular injuries

Lung cancer screening: No more excuses

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Pleomorphic carcinoma of the lung: A surgical outcome

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Pulmonary hypertension in valve disease: A beast of the past?

Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases Toshihiko Sato, MD,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Sleeve lung resection for lung cancer: Analysis according to the type of procedure Kazumichi Yamamoto, MD, Yoshihiro Miyamoto, MD, Akihiro Ohsumi, MD,

Go on-pump or off-pump in diabetic patients?

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

It's not “just a shunt” but sometimes it should be…

Bartley P. Griffith, MD, FACS, FRCS

Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality Christopher M. Pezzi, MD, Katherine Mallin, PhD, Andres Samayoa.

A first start for lung transplantation?

Commentary: Tag, you're it

Stephen R. Broderick, MD, MPHS

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Left sinus of Valsalva aneurysm: Rare disease, rarer presentation

Is endoluminal vacuum therapy “sponge worthy”?

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Taking UP the chronic pulmonary obstructive disease gauntlet

Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Stage III thymoma: Relationship of local invasion to recurrence

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

The continuing challenge of congenital heart disease in China

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Junaid Haroon, MD, Subroto Paul, MD, MPH

Aritoshi Hattori, MD, Kenji Suzuki, MD

Apples remain apples NO matter what

Energized lung resections

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Salvage surgery for advanced non–small cell lung cancer after response to gefitinib Tomoyuki Hishida, MD, Kanji Nagai, MD, Tetsuya Mitsudomi, MD, Kohei.

Preoperative PFTs: The answer is blowing in the wind

Who should decide margin length in pulmonary excision of lung cancer?

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Deciding how much to pay for effective care

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori, MD, Tetsuya Koyanagi, MD, Shinji Nakashima, MD, PhD, Tohru Mawatari, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 136, Issue 5, Pages 1357-1363.e2 (November 2008) DOI: 10.1016/j.jtcvs.2008.07.016 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial cumulative survival curve in patients with pathologic stage I lung cancer. UIP, Usual interstitial pneumonia. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1357-1363.e2DOI: (10.1016/j.jtcvs.2008.07.016) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial cumulative disease-free survival curve in patients with pathologic stage I lung cancer. UIP, Usual interstitial pneumonia. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1357-1363.e2DOI: (10.1016/j.jtcvs.2008.07.016) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions